A Peek into Vertex Pharmaceuticals Inc Shares

A Peek into Vertex Pharmaceuticals Inc SharesVertex Pharmaceuticals Inc's director Joshua S. Boger sold 5,140 shares of Boston, Massachusetts based Vertex Pharmaceuticals stock on Wednesday, July 6th. The total transaction was $457,408.60 at an average price of $88.99.

After the sale the director currently owns 273,365 shares of the company's stock as disclosed in a legal filing with the SEC.

On Friday, Vertex Pharmaceuticals shares were down 0.98 percent touching $89.17. The exchange volume was 354,042 shares. The company has a fifty two weeks low $75.90 and a fifty week high of $143.45. The stock has a market capitalization of $22.06 billion. Its fifty day moving average is $88.81 and two hundred day moving average is $90.49.

The company announced its quarterly earnings last time on April 27th. For that quarter the company reported $0.09 EPS which missed estimates of $0.29. In the quarter, the company reported revenue of $398.10 again missing the analysts' expectations of $439.94 million.

Many equities analysts issued reports on the stock with Cowen and Company giving it 'hold' in a report on 17th April. On 18th June, Piper Jaffray Cos. reissued a 'buy' rating for Vertex Pharmaceuticals shares. The shares also got a 'buy' rating from Royal Bank of Canada on 19th.